Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × exemestane × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Carcinoma, Intraductal, Noninfiltrating 3 Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Endometrial Neoplasms 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Acrocephalosyndactylia 1

Interventions

ribociclib 1 exemestane 1 Leuprolide 1 Letrozole 1 Immunotherapy 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05827081 2026-03-02

Adjuvant WIDER

Novartis

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡